Evidence map›Paper›PMID 40864227›Full record

ArticleBlood advances2025

A mouse model for hemoglobin SC disease recapitulates characteristic human pathologies.

Jinbin Zhai, James B Papizan, Yu Yao, Elizabeth D Arnold, Jing Yu, Tam Tran, Natalie Geiger, Jahnavi Gollamudi, Danielle R Little, Ravirajsinh N Jadeja and 19 more

Abstract read
In one paragraph

Article in Blood advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. A tale of 2 mice.Blood advances · 2025
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

Jinbin ZhaiCenter for Advanced Genome Engineering, Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN.
James B PapizanCenter for Advanced Genome Engineering, Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN.
Yu YaoDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN.
Elizabeth D ArnoldCenter for Advanced Genome Engineering, Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0009-0000-8916-667X
Jing YuDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN.
Tam TranCenter of Excellence for Leukemia Studies, Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN.
Natalie GeigerDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-2665-2483
Jahnavi GollamudiDepartment of Internal Medicine, University of Cincinnati, Cincinnati, OH.ORCID 0000-0003-2992-6264
Danielle R LittleDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0001-7262-1496
Ravirajsinh N JadejaDepartment of Biochemistry and Molecular Biology, Medical College of Georgia at Augusta University, Augusta, GA.
Jaison JohnCenter for Bioimage Informatics, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0009-0000-2825-0675
Ali KhalighifarCenter for Bioimage Informatics, St. Jude Children's Research Hospital, Memphis, TN.
Kalin MayberryDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0009-0002-6582-1806
Justina McEvoyDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN.
Randi RooneyDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN.
Krishnan VenkataramanCenter for Bioimage Informatics, St. Jude Children's Research Hospital, Memphis, TN.
Hieu S VuCenter of Excellence for Leukemia Studies, Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN.
Jingjing ZhangDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN.
Michael DyerDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN.
Patrick G GallagherDepartment of Pediatrics, Center for Perinatal Research, Abigail Wexner Research Institute, Nationwide Children's Hospital, The Ohio State University, Columbus, OH.ORCID 0000-0002-5424-0224
Hyacinth I HyacinthDepartment of Neurology and Rehabilitation Medicine, University of Cincinnati College of Medicine, Cincinnati, OH.
Laura J JankeComparative Pathology Core, Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN.
Pamela M MartinDepartment of Biomedical Sciences, School of Graduate Studies, Meharry Medical College, Nashville, TN.ORCID 0000-0001-6278-4953
Min NiDivision of Molecular Oncology, Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-4587-1622
Jian XuCenter of Excellence for Leukemia Studies, Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN.
Jonathan S YenDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN.
Yan ZhengDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0001-7254-7564
Mitchell J WeissDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN.
Shondra M Pruett-MillerCenter for Advanced Genome Engineering, Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-3793-585X

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Shondra Michelle Miller · 1985 to 2026
$166.9M
Novel therapeutic gene editing to induce fetal hemoglobin for sickle cell diseaseU01HL163983 · NHLBI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Akshay Sharma, Shengdar Tsai · 2023 to 2026
$4.9M
Molecular Analysis of Transcriptional Enhancers in HematopoiesisR01DK111430 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI Jian Xu · 2016 to 2026
$4.8M
Sickle cell disease and the functional circuit of adult-born neurons in the dentate gyrusR01HL156024 · NHLBI · UNIVERSITY OF CINCINNATI · PI HYACINTH, HYACINTH IDU · 2021 to 2025
$4.0M
NCI NIH HHS P30 CA021765NHLBI NIH HHS R01 HL156024NHLBI NIH HHS U01 HL163983NIDDK NIH HHS R01 DK111430
6 · The paper itself

Abstract

abstractSickle cell disease (SCD) is a common, life-threatening group of disorders caused by missense mutations in the β-globin gene (HBB). Mouse models have helped to elucidate the most common form of SCD (hemoglobin SS [HbSS]; homozygous p.Glu6Val) and develop new therapies. In contrast, a lack of animal models has restricted research on the second most common form of SCD (hemoglobin SC [HbSC]; p.Glu6Val/p.Glu6Lys). We used CRISPR genome engineering to generate HbSC alleles in the Townes mouse strain, which harbors human α- and β-globin genes in place of the mouse counterparts. Compared to Townes HbSS mice, HbSC mice exhibited signature pathologies that distinguish HbSC disease in humans.

Indexed as

Anemia, Sickle CellDisease Models, AnimalHemoglobin SC DiseaseAllelesalpha-GlobinsAnimalsbeta-GlobinsHumansMicealpha-Globinsbeta-Globins

Identifiers

PMID40864227
PMCPMC12745012

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.